Sponsor

Arla Foods

Clinical research sponsor

Published trials14
Recruiting shown0
Roles1
SourceClinicalTrials.gov

Clinical trials

14 shown
Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box StudyNCT05330247 · collaborator · 2022-09-27
COMPLETED
Fermented Dairy Products and The Metabolic SyndromeNCT04755530 · collaborator · 2021-02-25
COMPLETED
Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes. The Hypo-energetic StudyNCT03814694 · collaborator · 2019-01-29
COMPLETED
The Effect of Dairy Fat and Inulin on Fasting Induced Adipose Factor (FIAF) Blood ConcentrationsNCT01913678 · collaborator · 2013-07-01
COMPLETED
The Effect of Hydrolyzed Casein on Energy Expenditure and Subjective AppetiteNCT01677273 · collaborator · 2012-09-01
COMPLETED
The Effect of Protein and Calcium on Weight Change and Blood Lipid ProfileNCT01561131 · collaborator · 2012-01-01
COMPLETED
Dairy Lipids, Proteins, and the Metabolic Syndrome - "DairyHealth"NCT01472666 · collaborator · 2011-10-01
COMPLETED
Targeting the Gut Microbiome to Investigate the Pathways of Progression From Obesity to Metabolic Diseases in an At-risk Population.NCT01433120 · collaborator · 2011-09-01
COMPLETED
Dairy Proteins and Postprandial Appetite Regulation and Energy ExpenditureNCT01133964 · collaborator · 2008-10-01
COMPLETED
Effects of Dietary Proteins on Postprandial Lipaemia and Incretin Responses in Obese SubjectsNCT00809874 · collaborator · 2008-02-01
COMPLETED
The Effect of Calcium on Fecal Fat and Energy ExcretionNCT00519909 · collaborator · 2007-08-01
UNKNOWN
The Effect of Calcium on Postprandial Lipid Profile and AppetiteNCT00464035 · collaborator · 2005-02-01
COMPLETED
The Effect of Whey and Casein on IGFs in Prepubertal BoysNCT00378820 · collaborator · 2004-07-01
UNKNOWN
Differential Effects of Milk Proteins on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 DiabetesNCT00819975 · collaborator
COMPLETED

Sponsor roles

collaborator14

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.